反応式
[OH:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([Br:8])[N:3]=1.[OH-].[Na+].Cl[CH2:12][C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[CH2:19][C:20]([O:22][CH3:23])=[O:21].O>C1OCCOCCOCCOCCOC1.C1(C)C=CC=CC=1.CN(C=O)C.[I-].[Na+]>[Br:8][C:4]1[N:3]=[C:2]([O:1][CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=2[CH2:19][C:20]([O:22][CH3:23])=[O:21])[CH:7]=[CH:6][CH:5]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 4
実験手順
A mixture of 2-hydroxy-6-bromopyridine (1.3 g, 7.5 mmol), sodium hydroxide (0.36 g, 9.0 mmol) and 15-crown-5 (1 drop) in dry toluene (20 ml) were stirred at reflux for 1.5 hours. The toluene was removed under reduced pressure and the white salt residue was dissolved in dry DMF (10 ml). Methyl 2-chloromethylphenylacetate (1.0 g, 5 mmol) in dry DMF (10 ml) was added dropwise along with sodium iodide (10 mg). The mixture was stirred at 80° C. for 2 hours, poured into water and extracted with diethyl ether. The ether extracts were washed with water, dried and the ether removed in vacuo leaving an orange oil which was purified by column chromatography (silica eluted with 10% ethyl acetate in hexane) to give methyl 2-(6-bromopyrid-2-yloxymethyl)phenylacetate (0.86 g, 51%) (Compound No. 2 in Table 1) as an orange oil; 1H NMR (270 MHz)δ: 3.68(3H,s), 3.73(2H,s), 5.38(2H,s), 6.68(1H,d), 7.06(1H,d), 7.25-7.50(5H,m) ppm.
後処理
- temperatureat reflux for 1.5 hours
- customThe toluene was removed under reduced pressure
- dissolutionthe white salt residue was dissolved in dry DMF (10 ml)
- stirringThe mixture was stirred at 80° C. for 2 hours
- extractionextracted with diethyl ether
- washThe ether extracts were washed with water
- customdried
- customthe ether removed in vacuo
- customleaving an orange oil which
- customwas purified by column chromatography (silica eluted with 10% ethyl acetate in hexane)
出典と根拠
- ORDレコード
- ord-2d2c758f19d640058b0f3b90bd5eaee6
- 出典データセット
- uspto-grants-2000_01
- 特許番号
- US06015905
関連ノート
読み込み中…